Healio (5/12, Herpen) reports, “Individuals with opioid use disorder [OUD] and polysubstance use were less likely to initiate treatment with buprenorphine and naltrexone than those without polysubstance use,” researchers concluded in a study that “sought to examine buprenorphine and naltrexone initiation among those diagnosed with” OUD, “with and without concurrent substance use disorder.” For the study, investigators “utilized insurance claims between 2011 and 2016 from United States IBM databases to find instances of medication initiation for OUD in 179,280 treatment-seeking individuals (50.5% male), aged 12 to 64 years, with a primary diagnosis of OUD.” The findings were published online May 10 in JAMA Network Open.
Related Links:
— “Those with opioid use disorder, polysubstance use less likely to initiate MOUD treatment “Robert Herpen, Healio, May 12, 2022